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Glycyl-histidyl-lysine-Cu2+ is a tripeptide±copper
complex previously shown to be an activator of
wound healing. We have investigated the effects of
glycyl-histidyl-lysine-Cu2+ on the synthesis of glycos-
aminoglycans and small proteoglycans in a model
of rat experimental wounds and in rat dermal ®bro-
blast cultures. Repeated injections of glycyl-histidyl-
lysine-Cu2+ (2mg per injection) stimulated the wound
tissue production, as appreciated by dry weight and
total protein measurements. This stimulation was
accompanied by an increased production of type I
collagen and glycosaminoglycans (assessed, respec-
tively, by hydroxyproline and uronic acid contents of
the chamber). Electrophoretic analysis of wound tissue
glycosaminoglycans showed an accumulation of chon-
droitin sulfate and dermatan sulfate in control wound
chambers, whereas the proportion of hyaluronic acid
decreased with time. The accumulation of chondroitin
sulfate and dermatan sulfate was enhanced by glycyl-
histidyl-lysine-Cu2+ treatment. The expression of two
small proteoglycans of the dermis, decorin and bigly-
can, was analyzed by northern blot. The biglycan
mRNA steady-state level in the chamber was maximal
at day 12, whereas the decorin mRNA increased pro-
gressively until the end of the experiment (day 22).
Glycyl-histidyl-lysine-Cu2+ treatment increased the
mRNA level of decorin and decreased those of bigly-
can. In dermal ®broblast cultures, the stimulation of
decorin expression by glycyl-histidyl-lysine-Cu2+ was
also found. In contrast, biglycan expression was not
modi®ed. These results show that the expression of
different proteoglycans in wound tissue are regulated
in a different manner during wound healing. The gly-
cyl-histidyl-lysine-Cu2+ complex is able to modulate
the expression of the extracellular matrix macromole-
cules differently during the wound repair process. Key
words: glycosaminoglycans/proteoglycans/wound healing. J
Invest Dermatol 115:962±968, 2000
C
utaneous wound healing is a complex and dynamic
process, which involves the coordinated and sequen-
tial deposition of extracellular matrix molecules,
leading to the formation of a resistant new tissue
(Clark, 1995). Among these molecules, glycosamino-
glycans (GAG) and proteoglycans (PG) are, with collagens and
®bronectin, the major components of the connective tissue
extracellular matrix (Chen and Abatangelo, 1999). In addition to
their structural functions, GAG and PG play a part in several
processes in relation to wound healing, such as cellular adhesion,
migration, and proliferation (Hocking et al, 1998). GAG and PG
were also shown to bind growth factors and locally modulate their
biologic activities. Among the small PG found in skin, decorin and
biglycan have raised considerable attention because they are
implicated in collagen ®brils organization. They are composed of
a leucine-rich repeats-containing core protein, on which are
attached one or two, respectively, chondroitin sulfate (CS) and/or
dermatan sulfate (DS) GAG chains. The inactivation of decorin
gene by homologous recombination (Danielson et al, 1997), but
not that of biglycan (Xu et al, 1998), was associated with a fragile
skin collagen network.
Numerous immunohistochemical studies have shown that GAG
and PG are present in granulation tissue and that their distribution is
altered in this tissue, in comparison with normal skin. The
repartition of GAG in wounds was shown to vary with time:
hyaluronic acid (HA) was prominent at the early phases of healing
whereas CS and DS accumulated during the later phases (Yeo et al,
1991).
Glycyl-L-histidyl-L-lysine (GHK) is a tripeptide that was isolated
from human plasma (Pickart and Thaler, 1973). This peptide
exhibits a high af®nity for copper(II) ions, with which it
spontaneously forms a tripeptide±copper complex (GHK-Cu).
GHK-Cu was initially described as a growth factor for a variety of
differentiated cells (Pickart, 1981). Subsequently, a number of other
biologic effects were reported and GHK-Cu appeared as a potent
activator of wound healing. For instance, it was described as a
chemotactic agent for monocytes/macrophages and mast cells
(Poole and Zetter, 1983; Zetter et al, 1985). Moreover, GHK-Cu
supported nerve tissue regeneration (Grosse and Lindner, 1980) and
stimulated angiogenesis in vivo (Raju et al, 1982; Lane et al, 1994).
We previously showed that GHK-Cu enhanced the expression of
extracellular matrix macromolecules both in vitro and in vivo
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(Maquart et al, 1993). When injected in super®cial wounds, GHK-
Cu accelerated wound closure (Downey et al, 1985; Pickart, 1987).
Clinical trials showed that GHK-Cu treatment might signi®cantly
improve the healing of skin ulcers in diabetic patients (Mulder et al,
1994). We also recently showed that GHK-Cu is able to modulate
tissue remodeling by selectively increasing the expression and
activation of gelatinase A (matrix metalloproteinase-2) (Simeon et al,
1999).
In this study, we investigated the effect of GHK-Cu on the
accumulation and the distribution of GAG during the different
phases of wound healing in vivo. The expression of decorin and
biglycan, two small PG of the dermis, were especially studied. For
that purpose, we used the in vivo wound chamber model described
by Schilling et al (1953) and in vitro rat dermal ®broblast cultures.
Our results demonstrate that GHK-Cu stimulates CS and DS
production, and decorin but not biglycan expression in vivo. In vitro
experiments demonstrate that ®broblasts were the main target cells
implicated in this effect.
MATERIALS AND METHODS
Animals Male Sprague±Dawley rats weighing between 250 and 300 g
were used in the experiments. They were provided by the Centre
d'Elevage DeÂpreÂ (St Doulchard, France). They were placed in individual
suspended stainless steel cages with food and water ad libitum.
Wound chambers Wound chambers were made of stainless steel wire
mesh cylinders (C-CX 20; EDMEC, Bellevue, WA) measuring
1 cm 3 2.5 cm long. They were closed at both ends by Te¯on caps and
sterilized by autoclaving.
Surgical procedures Rats were anesthetized by intraperitoneal
injection of sodium pentobarbital (40 mg per kg; Clin-Midy, Paris,
France). Dorsal hair was clipped widely from scapula to pelvis and the
nude area was sterilized with polyvidone iodine (Betadine; Laboratoire
Sarget, Merignac, France). Full-thickness skin incisions were made
perpendicular to the spine through the panniculus carnosus to the fascial
plane. A space that was approximately the same size as the chamber was
opened under the dermis and the sterile wound chambers with caps were
slipped beneath the skin. The incisions were closed through individual 4.0
nylon sutures.
Experimental design After separation at random, a group of rats was
used as controls and received the injections, directly into the chamber, of
0.2 ml of Dulbecco's phosphate-buffered saline on day 0, then twice a week
for 3 wk. The other group received the injections on the same days of the
same volume of Dulbecco's phosphate-buffered saline containing 2 mg
GHK-Cu (Procyte Corporation, Kirkland, WA) per injection. Groups of
six to eight rats depending on the experiments (three to four controls and
three to four GHK-Cu injected) were killed on days 3, 7, 12, 18, or 22
after chamber implantation. Wound ¯uid was immediately collected by
aspiration with a 1 ml sterile syringe and discarded. The material deposited
in the chambers was collected with a scalpel and frozen at ±80°C until
analysis.
Biochemical analysis of the chamber content Deposited material
was lyophilized and weighted. It was then dissolved in 0.5 M NaOH for
30 min at 60°C. After neutralization, ethanol was added to the ®nal
concentration of 80% (mass/vol). After 18 h at 4°C and centrifugation at
5000 3 g for 30 min, supernatant was collected, the pellet resuspended in
saline, and the ethanol precipitation repeated once for elimination of the
pigments that could interfere in subsequent assays. The ethanol precipitate
was redissolved in 0.5 M NaOH and an aliquot was taken for measurements
of total proteins by the method of Lowry et al (1951). The remaining
fraction was used for the measurement of collagen and GAG.
Collagen was measured by its hydroxyproline content. An aliquot of the
NaOH-solubilized material was hydrolyzed in 6 M HCl at 110°C for 18 h.
Hydroxyproline was then quantitated in the hydrolysate (Szymanowicz and
Laurain, 1981).
For GAG analysis, another aliquot was neutralized with acetic acid, and
digested with pronase in 0.05 M Tris±HCl, pH 8.0, 0.02 M CaCl2, for 24 h
at 48°C to release the GAG chains. Pronase was precipitated by the
addition of trichloroacetic acid to the hydrolysate to 10% (mass/vol) ®nal
concentration. The samples were centrifuged at 5000 3 g for 15 min and
the supernatant was dialyzed exhaustively against distilled water at 4°C. An
aliquot of the nondialyzable material was used for the measurement of
uronic acid according to Bitter and Muir (1962). The separation of the
GAG was carried out on cellulose acetate gel (Chemetron, Milano, Italy).
An aliquot containing 2 mg of total uronic acid for each sample was applied
on the membrane and electrophoresis was performed in 0.1 M zinc acetate,
pH 5.0, for 80 min at 80 V followed by electrophoresis in 0.1 M HCl for
20 min at 40 V. Standards were deposited together with the sample in order
to identify the position of the separated bands after migration. The
membrane was then ®xed in absolute ethanol and stained with 0.2% Alcian
blue in buffer (MgCl2 50 mM, sodium acetate 25 mM, pH 5.8, 50%
ethanol) for 20 min and destained three times in the same buffer. The GAG
distribution was determined after scanning the strips with a Vilber±Lourmat
image analyzer.
GAG identi®cation was done on samples collected at day 18. Aliquots
containing 6 mg of total uronic acid were hydrolyzed with either 10 units
streptococcal hyaluronidase per ml (Seikagaku Kogyo, Tokyo, Japan) in
0.1 M sodium acetate, pH 5.4 at 60°C for 1 h or with 1 unit chondroitinase
AC per ml in 0.2 M Tris, 0.2 M sodium acetate, pH 7.3 at 37°C for 5 h
(Lagunoff and Warren, 1962). Heparan sulfate was identi®ed after
deaminative cleavage with 1.8% NaNO2 in 10% acetic acid for 90 min at
room temperature (Saito et al, 1968).
In vitro experiments Dermal ®broblasts from explants of rat skin were
grown to con¯uence in plastic 75 cm2 ¯asks (Life Technologies, Cergy-
Pontoise, France) in Dulbecco's modi®ed Eagle's medium containing 10%
fetal bovine serum. After three washes with phosphate buffered saline, the
cells were incubated for 24 h in Dulbecco's modi®ed Eagle's medium
supplemented with 1.5% fetal bovine serum with or without 10±9 M GHK-
Cu. Cultured cells between the third and the sixth passage were used in this
study.
RNA extraction The wound chambers were frozen in liquid nitrogen
immediately after collection. Once deep frozen, the wound chamber
content was collected using a scalpel and homogenized in a 4 M
guanidinium±thiocyanate/phenol mixture (Tri Reagent, Euromedex,
Souffelweyersheim, France). Total RNA was extracted according to the
instructions of the manufacturer using the single-step method of
Chomczynski and Sacchi (1987).
Northern blotting Ten micrograms of RNA were dissolved in 50%
formamide, 2.2 M formaldehyde, 0.1 M 3-[N-morpholino]-propane
sulfonic acid, pH 7.0, 40 mM sodium acetate, 5 mM ethylenediamine
tetraacetic acid, pH 8.0, and denatured by heating at 65°C for 15 min.
RNA was then fractionated by electrophoresis in 1% agarose/formaldehyde
gel for 6 h at 70 V (Sambrook et al, 1989) and transferred overnight by
capillary blotting in 20 3 standard saline citrate solution (1 3 SSC = 0.15 M
NaCl, 0.015 M sodium citrate, pH 7.0) to nylon ®lter (Genescreen plus,
NEN, Boston, MA). The air-dried nylon ®lter was ultraviolet-irradiated for
5 min to bind transferred RNA.
The ®lter was prehybridized for 18 h at 42°C in a 10% sodium dodecyl
sulfate (SDS), 5 3 SSC, 5 3 Denhardt's solution, 250 mg per ml of
denatured salmon sperm DNA, and 50% formamide. Speci®c hybridization
was carried out overnight in the same solution with addition of 106 cpm
per ml of 32P-labeled cDNA probe. The ®lter was washed twice in 2 3
SSC, 0.1% SDS at 42°C, once in 0.1 3 SSC, 0.1% SDS at 65°C and
exposed to autoradiography at ±80°C using hyper®lm MP (Amersham Life
Science, Amersham, Bucks, U.K.) and Kodak X-Omat cassette C2 with
intensifying screens.
Autoradiographic signals were scanned on a Molecular Imager System
GS-63 (Bio-Rad Laboratories, Richmond, CA) and quantitated with
Molecular Analyst software (Bio-Rad Laboratories).
Decorin immunoprecipitation Rat ®broblasts were cultured in
25 cm2 ¯asks to con¯uency and incubated for 24 h in Dulbecco's
modi®ed Eagle's medium supplemented with 1.5% fetal bovine serum
with or without 10±9 M GHK-Cu. After three washes with phosphate-
buffered saline, the cells were incubated for 7 h with 740 kBq [35S]sulfate in
sulfate±low minimum essential medium with or without 10±9 M GHK-Cu.
At the end of the incubation period, culture media were supplemented
with proteinase inhibitors, 0.1% (wt/vol) Na2SO4. A 700 ml aliquot of each
sample was precipitated with 66% acetone and analyzed by SDS±
polyacrylamide gel electrophoresis (7.5% acrylamide). The PG decorin
was immunoprecipitated from 1 ml of culture medium using a speci®c anti-
decorin antibody (LF-113, generous gift of Dr. Larry Fisher, NIDR,
Bethesda) according to previously described methods (Wegrowski et al,
1995a). The immune complex was collected by adsorption on protein A±
protein G±Sepharose beads and analyzed by SDS±polyacrylamide gel
electrophoresis and autoradiography.
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cDNA probes Plasmid used was pBluescript SK containing an insert for
mouse decorin core protein, or an insert for mouse biglycan core protein
cDNA (generous gifts of Dr. Larry Fisher, NIH, Bethesda, MD) (Fisher
et al, 1995). The GPDN5 plasmid containing the full-length rat
glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) cDNA was used
as reference (generous gift of Dr. P. Fort, Montpellier, France) (Fort et al,
1985). cDNA were excised from their plasmids with appropriate restriction
enzymes, and labeled with random priming using Prime It II kit
(Stratagene, La Jolla, CA). The labeled cDNA probe was separated from
32P-deoxycytidine triphosphate by chromatography through a G-50 spin
column.
Statistical analysis All the experiments were performed in triplicate or
quadruplicate, depending on the experiment. Quantitative data were
expressed as mean 6 1 SEM. Statistical analysis was done by the Student's t
test or the Mann±Whitney U test.
RESULTS
GHK-Cu increases collagen and GAG accumulation in
wound chambers Wound chambers injected with 2.0 mg
GHK-Cu or with Dulbecco's phosphate-buffered saline were
collected at different intervals after implantation and wound tissues
were studied by biochemical analysis. Hydroxyproline and uronic
acid were used as an index of collagen and GAG contents,
respectively. Collagen content of the wound tissue increased
progressively throughout the experiment in the control rats
(Fig 1A). GHK-Cu injections signi®cantly increased the collagen
content of the wound chambers at days 18 and 22 (396% and 538%
of the corresponding controls, respectively, p < 0.05).
In parallel to collagen, there was a progressive accumulation of
GAG in wound chambers, as measured by total uronic acid content
(Fig 1B). The increase was statistically signi®cant at days 12, 18,
and 22 (191%, 180%, and 179% of the corresponding controls,
respectively, p < 0.05).
GHK-Cu modulates the distribution of GAG in wound
tissue As GHK-Cu increased accumulation of GAG in the
wound tissue, we investigated whether its effect was
undifferentiated on all the GAG chains or if it speci®cally
modulated their relative repartition. GAG species in wound tissue
were identi®ed by cellulose acetate electrophoresis (Fig 2).
Enzymatic and chemical degradations permitted us to identify
three mains bands corresponding to HA, DS, and CS. A minor
band corresponding to heparan sulfate was also detected (Fig 2, lane
1). Streptococcal hyaluronidase speci®cally hydrolyzed HA (Fig 2,
lane 2) and chondroitinase AC hydrolyzed CS and HA (lane 3). The
weak, diffuse band was completely degraded after NaNO2
treatment (Fig 2, lane 4), which shows that it corresponds to
heparan sulfate. This fraction, representing less than 2% of total
GAG, was not studied further.
The relative distribution of GAG varied with time. In the wound
tissue extracted from control rats, the HA part decreased (25% of
total GAG at day 7 versus 6% at day 22) whereas the CS/DS part
increased with a predominance of DS (70% of total GAG at day
22). GHK-Cu injections modi®ed this distribution by increasing
the relative CS content. Quantitation by image analysis showed
that, at day 18, the percentages of CS/DS/HA were 26%/68%/6%
in the control wound tissue compared with 44%/49%/7% in the
GHK-Cu treated one. At day 22, the percentages of CS/DS/HA
were 22%/68%/10% in the control group versus 37%/53%/10% in
the treated group (Fig 3).
Kinetic measurement of the amount of each GAG species in the
wound chambers showed a relative stability of the HA content
from day 7 to day 22 in the control group (Fig 4A). GHK-Cu
injections enhanced HA content at days 12 and 22, as compared
with the control. On the other hand, DS and CS contents increased
progressively in control wound chambers throughout the experi-
ment (Fig 4B, C). GHK-Cu injections did not signi®cantly affect
the accumulation of DS but increased that of CS. At days 18 and
22, the CS content in the GHK-Cu injected wound chamber was
2.8 (p < 0.01) and 3.1-fold (p < 0.05) higher than in the
corresponding controls.
Decorin and biglycan expression are differentially modulated
by GHK-Cu in vivo The galactosaminoglycans, DS and CS, exist
in the tissues in PG form. In skin, two major species of DS/CS-
containing small PG are present: decorin and biglycan. We studied,
using northern blot, the expression of these PG in the wound
chambers. GAPDH expression was studied in parallel as a
housekeeping gene. Autoradiographic analysis showed the
expression of only one transcript for each gene, migrating at 1.9 kb,
Figure 1. GHK-Cu increases the accumulation of collagen and
GAG in wound chamber. Chambers were injected twice a week with
(s) or without (d) GHK-Cu, 2.0 mg per injection. Rats were killed and
chambers collected to measure hydroxyproline (A) and uronic acid (B)
contents at days 7, 12, 18, or 22 as described in Materials and Methods.
Symbols represent individual results for the four rats. Means are shown by
horizontal bars.
Figure 2. Chondroitin-sulfate, dermatan-sulfate, and hyaluronic
acid are the major GAG present in the wound tissue. CS,
chondroitin-sulfate; DS, dermatan-sulfate; HS, heparan-sulfate; HA,
hyaluronic acid. Identi®cation of the wound tissue GAG collected from
wound chambers at day 18. (A) Chambers injected with saline solution. (B)
Chambers injected with 2 mg GHK-Cu. Samples were analyzed by
cellulose acetate electrophoresis without prior treatment (lane 1) or after
digestion with streptococcal hyaluronidase (lane 2), chondroitinase AC (lane
3), and NaNO2 (lane 4).
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2.8 kb, and 1.2 kb for decorin, biglycan, and GAPDH, respectively.
These sizes are those usually described in the literature. In our
experimental conditions, decorin andbiglycan mRNA weredetected
from day 7 to 22 (Fig 5A). We observed strong differences in their
expressions during the wound repair process. Decorin mRNA
increased progressively throughout the experiment (Fig 5B),
whereas biglycan mRNA increased during the ®rst days to reach a
plateau at day 12 (Fig 5C).
GHK-Cu injections signi®cantly increased the decorin mRNA
steady-state level (+73%, p < 0.05 at day 22) and decreased that of
biglycan (±45%, p < 0.05 at day 18 and ±26%, p < 0.05 at day 22).
Decorin and biglycan expressions in cultured ®broblasts are
differentially affected by GHK-Cu Con¯uent dermal rat
®broblasts were cultured during 24 h in Dulbecco's modi®ed
Eagle's medium containing 1.5% fetal bovine serum, with or
without GHK-Cu (10±9 M). Northern blots were then performed
to study the mRNA steady-state levels of decorin and biglycan
(Fig 6A). The same transcripts as those observed in the wound
tissue were found in the ®broblast cultures. Compared with
GAPDH, decorin mRNA expression was increased with GHK-Cu
(302% of the controls, p < 0.05) (Fig 6B), whereas biglycan
expression was not signi®cantly affected (Fig 6C).
Immunoprecipitation of the culture medium with a speci®c anti-
decorin antibody con®rmed the enhancement of decorin produc-
tion by the ®broblasts incubated with GHK-Cu (Fig 7).
DISCUSSION
GAG and PG are constituents of the granulation tissue of normal or
pathologic wounds (Yeo et al, 1991). In this study we studied the
accumulation of GAG and small PG in the wound chamber model
described by Schilling et al (1959) and their modulation by the
tripeptide±copper complex, GHK-Cu. The wound chamber
represents a model of dermal healing. After 4 wk of healing, the
chambers are nearly ®lled with newly formed connective tissue.
We used this model successfully to demonstrate the stimulating
effect of GHK-Cu on connective tissue accumulation and
remodeling in rat wounds (Maquart et al, 1993; Simeon et al,
1999). The expression pattern of small PG during dermal wound
healing has never been studied before.
Biochemical analysis of the wound chambers con®rmed that
GHK-Cu injections increased GAG and collagen deposition.
Interestingly, we noticed that glucuronic acid deposition occurred
rapidly in the wound, whereas collagen deposition, appreciated by
its hydroxyproline content, was slower. This suggests that GAG
Figure 4. GAG deposition in the wound
chambers is increased by GHK-Cu. The same
amount of total GAG (2 mg of uronic acid) were
deposited on each lane and separated by electro-
phoresis as described in Fig 2. Hyaluronic acid
(A), dermatan sulfate (B), chondroitin sulfate (C)
contents were determined by densitometric
scanning after correction for the uronic acid con-
tent of the wound chamber. Results are mean of
three determinations 6 1 SEM
Figure 3. GAG distribution in the wound
tissue is altered by GHK-Cu. (A) Separation
and identi®cation of GAG by cellulose acetate
electrophoresis. Two micrograms of uronic acid
were deposited on each lane. The day of sample
collection for analysis is indicated above the pic-
ture. The migration position of reference GAG
are indicated by arrows: (HA) hyaluronic acid
(HS) heparan sulfate (DS) dermatan sulfate (CS)
chondroitin sulfate. (B) Distribution of GAG in
wound tissue. Signals from (A) were scanned on a
Vilber-Lourmat Image Analyzer and quantitated
with Bio1D software.
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may play an important part in the initial phases of the wound tissue
formation.
Electrophoretic analysis of the GAG chains showed that HA, DS,
and CS were the major GAG of the wound chamber throughout
the analysis. Heparan sulfate was not quantitated in our study
because this GAG was present in too small an amount (less than 2%
of total GAG) in the wound chambers. HA represented between
25% at day 7 and 6% at day 22 of the total GAG content. The raw
amount of HA per chamber remained nearly constant throughout
the experiment. The relative reduction of HA content in
comparison with sulfated GAG con®rmed previous studies that
showed early hyaluronan deposition was followed by sulfated GAG
accumulation (Clark, 1995). In normal dermis, HA and DS are the
most abundant GAG. In the wound tissue, CS, a minor component
of the normal dermis, was increased up to 45% of the total GAG.
Similar data were reported by Yeo et al (1991) and Lamme et al
(1996) in full-thickness wounds performed in guinea pigs or
Yorkshire pigs, respectively. It may re¯ect a decreased activity of
glucuronate epimerase in healing tissue and/or the preferential
accumulation of other type(s) of PG in healing tissue, for example
versican. GHK-Cu injections altered the GAG distribution in the
wound tissue. We noted a strong stimulation by GHK-Cu of the
CS accumulation and, to a lesser extent, of DS. Previous works
from our laboratory showed that GHK-Cu stimulated DS synthesis
by cultured human dermal ®broblasts, but had no effect on the CS
synthesis (Wegrowski et al, 1992a). Taken together, these
differences between in vitro and in vivo data re¯ect the crucial part
of the cellular environment on the cellular behavior during wound
healing.
Quantitation of the different GAG extracted from the wound
tissue was based on quantitation of the Alcian blue staining after
electrophoretic separation. Alcian blue staining may depend on the
charge density along the GAG chain. This study, however, was
comparative and designed to follow GAG deposition in the wounds
under different conditions. For that reason, we used a method able
to screen a large number of samples. The small variations of staining
that may be caused by differences of charge density cannot explain
the large differences in the relative amounts of the different varieties
of GAG that we observed.
The signi®cant increase of CS in wounds treated with GHK-Cu
prompted us to explore the CS/DS-containing PG. In the dermal
extracellular matrix, galactosaminoglycans, i.e., DS and CS, are
present in the large, aggregating PG versican, but also in two small,
nonaggregant PG: biglycan and decorin. This study focused on
these small PG only, because they are highly expressed in normal
wound tissue. Their mRNA was not detected in the early stages of
wound healing (day 3), but appeared at day 7. They had different
expression patterns during wound tissue formation. Biglycan
mRNA increased rapidly to reach a plateau at day 12, whereas
decorin mRNA increased throughout the experiment. This
difference in their kinetics of expression might be explained by
the cellular types responsible for their synthesis. Decorin is
synthetized exclusively by the cells from mesenchymal origin
(Wegrowski et al, 1995b), whereas biglycan, in addition to
®broblasts, may be synthesized by epithelial and endothelial cells
(Bianco et al, 1990). The increase of decorin expression may re¯ect
the accumulation of ®broblasts in the chambers. Our results are in
agreement with those reported by Oksala et al (1995) in
experimental wounds of the human palatal mucosa, who found a
strong positive signal for decorin but no signal for biglycan at day 7.
Similar to our results, the biglycan mRNA expression in the
infarcted zone was enhanced at days 2 and 7 in experimentally
induced myocardial infarction in rats (Yamamoto et al, 1998).
It must be noted that modi®cations of the GAG distribution
pattern, on the one hand, and of core proteins of biglycan and
decorin, on the other, do not exclude the fact that structural
alterations of the GAG moieties of the molecules may occur.
Further studies will be necessary to compare the ®ne structure of
Figure 5. Decorin and biglycan expression
are differentially regulated during wound
healing. (A) Northern blot analysis of decorin,
biglycan, and GAPDH mRNA in the wound
chambers injected with 2.0 mg GHK(+) or with
saline (controls, ±) twice a week from days 0 to
21. The day of sample collection for analysis is in-
dicated. (B, C) mRNA steady-state levels were
expressed by the ratio of decorin (B) or biglycan
(C) to GAPDH mRNA in wound chambers in-
jected (hatched bars) or not (controls, open bars)
with GHK-Cu. Results are mean of three deter-
minations 6 1 SEM.
Figure 6. Decorin but not biglycan expression by cultured rat
®broblasts are stimulated by GHK-Cu. (A) Northern blot analysis of
decorin, biglycan, and GAPDH mRNA in rat skin ®broblasts cultured with
or without 10±9 M GHK-Cu for 24 h (B, C): Expression of steady-state
levels of decorin (B) or biglycan (C) to GAPDH mRNA in ®broblasts
cultured with (hatched bars) or without (controls, open bars) 10±9 M GHK-
Cu. Results are mean of three determinations 6 1 SEM.
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decorin and biglycan GAG chains during the early and late phases
of wound healing. Our study shows for the ®rst time a differential
regulation of the two small PG, decorin and biglycan, mRNA in
wounds. GHK-Cu was able to modulate the steady-state mRNA
levels of both PG. In the later stages of wound healing (days 18 and
22), it increased the decorin mRNA, whereas it decreased biglycan.
A differential regulation of biglycan and decorin was also observed
in bleomycin-induced pulmonary ®brosis in rats (Westergren-
Thorsson et al, 1993). In vitro studies showed that transforming
growth factor (TGF) -b upregulates biglycan, whereas it down-
regulates decorin synthesis (Westergren-Thorsson et al, 1992b); on
the contrary, glucocorticoids downregulate biglycan and upregulate
decorin synthesis (Kimoto et al, 1994).
To study a direct effect of GHK-Cu on ®broblast PG synthesis,
we used cultured rat dermal ®broblasts and showed that GHK-Cu
increased the decorin mRNA steady-state levels in these cultures,
reproducing the effect observed in vivo. On the contrary, the
inhibiting effect of GHK-Cu on biglycan gene expression in vivo
was not reproduced in the cell culture model. These results show
that the effect GHK-Cu has on decorin mRNA in vivo concerns
mainly the ®broblasts whereas different types of cells may
contribute to biglycan synthesis. Further studies are needed to
elucidate the regulation of biglycan synthesis completely.
The increased decorin expression in wounds injected with
GHK-Cu is interesting in the context of wound healing. This PG is
involved in skin architecture, particularly by controlling collagen
®brillogenesis. Decorin interacts noncovalently with type I collagen
®brils (Scott et al, 1995) and contributes to the organization and
strength of the ®brillar network (Hocking et al, 1998). Recently,
Danielson et al (1997) observed that decorin gene invalidation leads
to skin fragility with markedly reduced tensile strength.
Decorin and biglycan may also act on wound tissue formation by
interactions with growth factors such as TGF-b (Scott et al, 1995).
The af®nity of both PG for TGF-b is, however, similar, and both
of them may be involved in the regulation of the TGF-b effects. A
recent report showed that dermatopontin, a 22 kDa extracellular
matrix protein, increases the biologic activity of TGF-b. Decorin,
by increasing the dermatopontin ability to bind TGF-b might also
increase the TGF-b activity (Okamoto et al, 1999). Another study
showed that DS released after injury is a potent promoter of
®broblast growth factor-2 function (Penc et al, 1998). By its ability
to increase GAG and/or PG accumulation in the wound tissue,
GHK-Cu may then act on the biodisponibility of different growth
factors and might facilitate some essential events of wound healing
such as cell proliferation, migration, and angiogenesis.
The increased decorin expression in the GHK-Cu-injected
wounds, with the increased collagen deposition, might contribute
to the formation of a mature extracellular matrix and may explain
the increased wound strength observed in the GHK-Cu-treated
wounds.
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